BioNxt Solutions Inc. XPHYF
0.28 +0.28
Day range unavailable
52-week range unavailable
No chart data for this range yet.
News
BioNxt Solutions Announces Closing of Shares for Debt Settlement 
Semaglutide API Delivery Enables Start of Lab-Scale ODF Development at BioNxt 
BioNxt's Sublingual Cladribine Program for MS Ready for Next Phase 
Bionxt Solutions Provides Bi-Weekly MCTO Status Report 
BioNxt Solutions Announces Closing of Second Tranche of Non-Brokered Private Placement 
BioNxt Solutions Announces Closing of Third and Final Tranche of Non-Brokered Private Placement 
BioNxt Solutions Announces Change of Directors 
XPhyto Therapeutics says director and founder Professor Dr Raimar Loebenberg receives leadership award from Canadian Society for Pharmaceutical Science 
XPhyto Therapeutics says pharmaceutical manufacturing expert Dr Florian A. Sahr has joined its European operations as project management head 
XPhyto Therapeutics advancing Rotigotine transdermal patch towards final pivotal study in fourth quarter this year
Your note
Sign in to keep a note on XPHYF — it syncs with the Stock Master app.